BRIEF published on 08/06/2024 at 08:35, 1 year 10 months ago Abivax Reaches Key Milestone with Recruitment of 600 Patients for Phase 3 ABTECT Trial Patient Recruitment Abivax Obefazimod Ulcerative Colitis Clinical Test
PRESS RELEASE published on 08/06/2024 at 08:30, 1 year 10 months ago Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone Abivax announces ABTECT Phase 3 Trial surpasses 600-patient enrollment milestone, on track for full enrollment by early Q1 2025. Trial trends align with previous observations Abivax Obefazimod Ulcerative Colitis ABTECT Phase 3 Trial Enrollment Milestone
BRIEF published on 07/23/2024 at 18:05, 1 year 10 months ago ABIVAX: Number of shares and voting rights as of June 30, 2024 Voting Rights Euronext Actions AMF Abivax
BRIEF published on 07/23/2024 at 18:05, 1 year 10 months ago ABIVAX: Half-yearly review of the liquidity contract as of June 30, 2024 Liquidity Contract Actions Financial Transactions Abivax First Half Of 2024
BRIEF published on 07/22/2024 at 09:51, 1 year 10 months ago Threshold crossing by Deep Track Biotechnology Master Fund Voting Rights Abivax Crossing Threshold Off-market Acquisition Deep Track Biotechnology
BRIEF published on 07/15/2024 at 22:05, 1 year 10 months ago Abivax announces advances in its clinical program and updates its operations Treasury Ulcerative Colitis Nomination Update Clinical Program
PRESS RELEASE published on 07/15/2024 at 22:00, 1 year 10 months ago Abivax Provides Operational and Key Program Update Abivax provides operational and key program update, including progress on clinical trials, leadership changes, and financial update Leadership Changes Abivax Clinical Trials Operational Update Financial Update
BRIEF published on 06/28/2024 at 18:05, 1 year 11 months ago ABIVAX: Summary of the Number of Shares and Voting Rights as of May 31, 2024 Voting Rights Actions AMF Abivax Transparency
BRIEF published on 05/29/2024 at 18:05, 2 years ago ABIVAX: Number of shares and voting rights as of April 30, 2024 Voting Rights Actions AMF Abivax Regulatory
BRIEF published on 05/08/2024 at 08:35, 2 years 1 month ago Presentation of Obefazimod for Ulcerative Colitis and Colon Cancer at DDW 2024 Abivax Obefazimod Ulcerative Colitis Digestive Disease Week Colon Cancer
Published on 06/10/2026 at 23:05, 1 hour 23 minutes ago Faraday Copper Announces Annual General Meeting Voting Results
Published on 06/10/2026 at 14:30, 9 hours 58 minutes ago Agassi Sports Entertainment Signs Tennis Coaching Icon Darren Cahill to Expand Global Coaching, Content and Technology Initiatives
Published on 06/10/2026 at 14:30, 9 hours 58 minutes ago Ondas to Launch LADOS, a Layered Autonomous Defense Operational C2 Layer, at Eurosatory 2026
Published on 06/10/2026 at 23:56, 32 minutes ago EQS-Adhoc: HUGO BOSS AG: HUGO BOSS informs about unsolicited voluntary takeover offer by Frasers Group plc
Published on 06/10/2026 at 22:05, 2 hours 23 minutes ago Ridgewood Infrastructure Acquires Dauntless Air, Premier Provider of Emergency Management Infrastructure
Published on 06/10/2026 at 21:45, 2 hours 43 minutes ago EQS-Adhoc: MAHLE has successfully priced the issuance of additional EUR 200 million notes due 2032 and is launching a partial tender offer for its outstanding notes due 2028
Published on 06/10/2026 at 20:11, 4 hours 17 minutes ago EQS-Adhoc: EDAG Engineering Group AG: Board of Directors resolves on capital measures to strengthen capital base
Published on 06/10/2026 at 18:39, 5 hours 49 minutes ago EQS-Adhoc: Kontron AG: Ad hoc announcement / Ennoconn Corporation intends to launch a mandatory takeover offer to Kontron AG shareholders
Published on 06/10/2026 at 18:29, 5 hours 59 minutes ago ICADE – PR – OUTCOME OF THE COMBINED GENERAL MEETING HELD ON JUNE 10 2026
Published on 06/10/2026 at 17:40, 6 hours 48 minutes ago Report on share repurchases from 3 to 9 June 2026
Published on 06/10/2026 at 07:00, 17 hours 28 minutes ago Acceleration of Museum Studio's international expansion
Published on 06/09/2026 at 19:30, 1 day 4 hours ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
